GT Biopharma GTBP
NASDAQ GTBP
$6.51 -0.29 (-4.26%)
As of: Sep 30, 2026 · 3:59 PM EDT

GT Biopharma (GTBP) EV to EBITDA (2019 - 2020)

Updated

GT Biopharma's (GTBP) EV to EBITDA stood at -0.44 in Q4 2020, compared with 0.00 a year earlier.

Analysis

GT Biopharma (GTBP) EV to EBITDA (2019 - 2020) Analysis & Trends

For FY2020, GT Biopharma's EV to EBITDA came in at -0.59.

  • Across earlier years, EV to EBITDA came in at 0.00 in FY2019.
  • Per Business Quant, the preceding three quarters came in at 0.00 (Q3 2020), -0.03 (Q2 2020) and 0.01 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 GT Biopharma 9.68 Mn 9.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -0.44
Sep 30, 2020 0.00
Jun 30, 2020 -0.03
Mar 31, 2020 0.01
Dec 31, 2019 0.00
API Access

GT Biopharma EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GTBP&period=max&api_key=YOUR_API_KEY